Clinical Trials Browser

Phase 1 × Bulbo-Spinal Atrophy, X-Linked × Clear all

NCT05241613 2025-02-13

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Bulbo-Spinal Atrophy, X-Linked

NCT05673109 2024-01-25

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Bulbo-Spinal Atrophy, X-Linked

NCT03478904 2021-05-10

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Phase 1 Terminated

1 enrolled 8 charts

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02162836 2020-04-27

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Prostatic Neoplasms, Castration-Resistant

NCT01351688 2013-07-03

An Open Label Prostate Cancer Study in Japanese Patients

Phase 1 Completed

Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Phase 1 Suspended

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked